Evidence map›Paper›PMID 26694191›Full record

ArticleBMC complementary and alternative medicine2015

Butein inhibits metastatic behavior in mouse melanoma cells through VEGF expression and translation-dependent signaling pathway regulation.

Yu-Wei Lai, Shih-Wei Wang, Chien-Hsin Chang, Shih-Chia Liu, Yu-Jen Chen, Chih-Wen Chi, Li-Pin Chiu, Shiou-Sheng Chen, Allen W Chiu, Ching-Hu Chung

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in BMC complementary and alternative medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Yu-Wei LaiDepartment of Urology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Shih-Wei WangDepartment of Medicine, Mackay Medical College, No. 46, Sec. 3, Jhong-Jheng Rd., Sanzhi Dist., Taipei, Taiwan.
Chien-Hsin ChangInstitute of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Shih-Chia LiuDepartment of Orthopaedics, Mackay Memorial Hospital, Taipei, Taiwan.
Yu-Jen ChenDepartment of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan.
Chih-Wen ChiDepartment of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan.
Li-Pin ChiuDepartment of Urology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Shiou-Sheng ChenDepartment of Urology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Allen W ChiuDepartment of Urology, National Yang-Ming University School of Medicine, Taipei, Taiwan.
Ching-Hu ChungDepartment of Medicine, Mackay Medical College, No. 46, Sec. 3, Jhong-Jheng Rd., Sanzhi Dist., Taipei, Taiwan. chchung@mmc.edu.tw.
Mackay Memorial Hospital · TWMackay Medical College · TWNational Yang Ming Chiao Tung University · TWNational Yang Ming Chiao Tung University · TWNational Taiwan University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMelanoma is an aggressive skin cancer and a predominant cause of skin cancer-related deaths. A previous study has demonstrated the ability of butein to inhibit tumor proliferation and invasion. However, the anti-metastatic mechanisms and in vivo effects of butein have not been fully elucidated.

methodsMTT cell viability assays were used to evaluate the antitumor effects of butein in vitro. Cytotoxic effects of butein were measured by lactate dehydrogenase assay. Anti-migratory effects of butein were evaluated by two-dimensional scratch and transwell migration assays. Signaling transduction and VEGF-releasing assays were measured by Western blotting and ELISA. We also conducted an experimental analysis of the metastatic potential of tumor cells injected into the tail vein of C57BL/6 mice.

resultsWe first demonstrated the effect of butein on cell viability at non-cytotoxic concentrations (1, 3, and 10 μM). In vitro, butein was found to inhibit the migration of B16F10 cells in a concentration-dependent manner using transwell and scratch assays. Butein had a dose-dependent effect on focal adhesion kinase, Akt, and ERK phosphorylation in B16F10 cells. Butein efficiently inhibited the mTOR/p70S6K translational inhibition machinery and decreased the production of VEGF in B16F10 cells. Furthermore, the in vivo antitumor effects of butein were demonstrated using a pulmonary metastasis model.

conclusionThe results of the present study indicate the potential utility of butein in the treatment of melanoma.

Indexed as

AnimalsCell ProliferationCell SurvivalChalconesHumansMaleMelanoma, ExperimentalMiceMice, Inbred C57BLNeoplasm MetastasisSignal TransductionSkin NeoplasmsVascular Endothelial Growth Factor AbuteinChalconesVascular Endothelial Growth Factor A

Identifiers

PMID26694191
PMCPMC4687249
OpenAlexW2221628456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.